Baronos Stamatis, Whitford Robert Charles, Adkins Kandis
Department of Cardiovascular and Thoracic Surgery, University of Louisville School of Medicine, Louisville, USA.
Indian J Thorac Cardiovasc Surg. 2023 Jul;39(Suppl 1):182-189. doi: 10.1007/s12055-022-01434-y. Epub 2022 Dec 16.
Heart failure is a leading cause of morbidity and mortality, the incidence of which is predicted to continue to increase as the population ages. Left ventricular assist devices (LVADs) in particular have emerged as important therapies for the support of patients with advanced heart failure needing short- or long-term mechanical circulatory support. With over 5000 implantations per year, LVADs are the most commonly used durable devices worldwide. In this article, we provide an overview of the intensive care management of patients with LVADs during the early post-implantation period.
心力衰竭是发病和死亡的主要原因,随着人口老龄化,预计其发病率将持续上升。特别是左心室辅助装置(LVAD)已成为支持需要短期或长期机械循环支持的晚期心力衰竭患者的重要治疗手段。LVAD每年植入超过5000例,是全球最常用的耐用装置。在本文中,我们概述了LVAD植入术后早期患者的重症监护管理。